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All somatic mammalian cells carry two copies of
chromosomes (diploidy), whereas organisms with
a single copy of their genome, such as yeast, provide
a basis for recessive genetics. Here we report the
generation of haploid mouse ESC lines from parthe-
nogenetic embryos. These cells carry 20 chromo-
somes, express stem cell markers, and develop
into all germ layers in vitro and in vivo. We also devel-
oped a reversible mutagenesis protocol that allows
saturated genetic recessive screens and results in
homozygous alleles. This system allowed us to gen-
erate a knockout cell line for the microRNA process-
ing enzyme Drosha. In a forward genetic screen, we
identified Gpr107 as a molecule essential for killing
by ricin, a toxin being used as a bioweapon. Our
results open the possibility of combining the power
of a haploid genome with pluripotency of embryonic
stem cells to uncover fundamental biological pro-
cesses in defined cell types at a genomic scale.
INTRODUCTION
Some organisms such as yeast or social insects are haploid, i.e.,
they carry a single set of chromosomes (Otto and Jarne, 2001).
Haploidy in yeast has been utilized to identify fundamental
mechanisms of biology (Hartwell et al., 1974). However, all
somatic mammalian cells carry two copies of chromosomes
(i.e. exhibit diploidy) that obscuremutational screens. Organisms
with a single copy of their genome, such as yeast, provide a basis
for genetic analyses where any recessive mutation of essential
genes will show a clear phenotype due to the absence of a
second gene copy (Hartwell et al., 1974). It has been shown re-
cently (Carette et al., 2009, 2011a, 2011b) that haploid mamma-
lian cells allow forward genetic screens. However, no somatic
haploid cell has ever been reported in mammals, likely becauseCelhaploidy is incompatible with mammalian development (Latham
et al., 2002). To this date, haploidy has been achieved in fish
embryonic stem cells (ESCs) (Yi et al., 2009) and human
KBM-7 leukemia cells (Carette et al., 2009, 2011a; Kotecki
et al., 1999), and by electrofusion to generate hybrid cells (Yan
et al., 2000).
Here we show that it is possible to generate mammalian
haploid ESC lines from parthenogenetic mouse blastocysts
derived from activated oocytes. Such cells show stable growth
over multiple passages, can be efficiently subcloned, differen-
tiate at similar kinetics as diploid ESCs, and can maintain
haploidy even upon initiation of differentiation. Moreover, we
provide evidence that haploid ESCs can be readily utilized for
reverse genetics and forward genetic screens. Our study pro-
vides the experimental framework for a system that carries
the promise to combine functional genomics with mammalian
stem cell biology.
RESULTS
Derivation of Haploid Cell Lines from Parthenogenetic
Murine Blastocysts
Parthenogenetic embryos develop from haploid oocytes and
thus contain only the maternal genome. However, all reported
cell lines derived from parthenogenetic embryos carry a diploid
set of chromosomes (Kaufman et al., 1983). We hypothesized
that haploid cells might still be present in parthenogenetic early
embryos and that haploid ESCs could be derived from such
blastocysts. To accomplish this, we activated oocytes from
superovulated C57BL/6 3 129 F1 females by exposing them to
5% ethanol. Activated oocytes were then transferred into pseu-
dopregnant recipients (Figure 1A). At embryonic day (ED) 3.5,
compacted morulae and blastocysts were harvested and culti-
vated under conditions used to derive ESCs. FACS analysis
showed that a small number of the parthenogenetically derived
cells indeed displayed a reduced DNA content (Figure S1A avail-
able online). Several rounds of FACS purification of this popula-
tion and subsequent expansion resulted in two independent cell
lines derived from two distinct blastocysts, hereafter termedl Stem Cell 9, 563–574, December 2, 2011 ª2011 Elsevier Inc. 563
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Figure 1. Generation of Haploid Murine ESC Lines
(A) Schematic overview of induction of parthenogenesis and the derivation of haploid ESC lines. Mouse oocytes were activated with either 5% ethanol [or 25 mM
strontium chloride (SrCl2)] and implanted into pseudopregnant females. ESCs were then generated from blastocysts and haploid cells subsequently sorted by
FACS. Cultures were routinely resorted until we derived stable haploid cells.
(B) Flow cytometric analysis of DNA content in the control diploid ESC line IB10/C and the haploid HMSc2 cell line. DNA content was determined using
Hoechst33342. 1n and 2n chromosome sets for haploid and 2n and 4n chromosome sets for diploid ESCs are indicated. The histograms show data from cells at
the tenth sort.
(C) Representative chromosome spreads of control diploid ESCs and haploid HMSc1 and HMSc2 cells. Spreads from anaphase (1n) and prophase (2n) of mitosis
are shown for haploid cells. As a control, anaphase (2n) and prophase (4n) spreads are shown for diploid ESCs.
(D and E) Sequence coverage relative to the common reference of parental in-house C57BL/6 and 129 strains is shown on a log2 scale. Haploid cells were derived
from C57BL/6 3 129 crosses. Chromosomes are arranged in numerical order and separated by small gaps.
See also Figure S1.
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Derivation of Murine Haploid Embryonic Stem CellsHMSc1 and HMSc2, with a 1n chromosome set in the G1 phase
and a 2n chromosome set in the G2 phase of the cell cycle (Fig-
ure 1B, Figure S1A). Chromosome spreads showed that both cell
lines carry a haploid set of 20 chromosomes (Figure 1C, Fig-
ure S1B). Of note, both cell lines have now been passaged >50
times without any signs of proliferative crisis. Thus, exploiting
activation of meiotic oocytes and parthenogenetic derivation of564 Cell Stem Cell 9, 563–574, December 2, 2011 ª2011 Elsevier Incblastocysts has allowed us to establish mouse cells with a
haploid chromosome set.
Genome Integrity
To genetically characterize our haploid cells, we compared their
genomes to the genomes of the parental in-house mouse strains
C57BL/6 and 129 using deep sequencing and performed.
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Derivation of Murine Haploid Embryonic Stem Cellsa discriminative coverage analysis. Briefly, we assessed the
counts of sequencing reads, not counting duplicates that map
to unique genomic positions, in a sliding window of 50 kb
(10 kb offset), normalized to the total number of reads that map-
ped to the genome in each library. As expected, we found that
the strains differed at many positions. We therefore compared
deep sequencing reads from genomic DNA of both our haploid
cell lines to both parental strains individually and in a combined
fashion in which we focused on deviations with respect to
both parental strain (Figures 1D and 1E). In total, we found
that HMSc1 differed from the parental strains by more than
2-fold (multiple-testing corrected p% 103) in 1,553 overlapping
windows corresponding to 219 nonoverlapping regions; HMSc2
had 568 windows (113 regions) with increased read-counts and
61 windows (10 regions) with decreased read-counts (R2-fold;
multiple-testing corrected p% 103; Table S1 available online).
Of note, 1,155 windows with increased read-counts and 99
windows with decreased read-counts overlapped between
HMSc1 and HMSc2, while only 397 and 4 were distinct, respec-
tively. We do not know the origin of this observation, but these
shared copy number variations (CNVs) might stem from biases
of the sequencing procedure during DNA preparation from
different cell types (ESCs versus adult kidney), or theymight con-
stitute a batch effect during sequencing. Thus, taken together,
our haploid cell lines display a limited number of defined CNVs
compared with the parent strains, suggesting that they likely
harbor small duplications and deletions, data similar to those
of previous reports using established ESC (Baker et al., 2007)
or iPSC (Hussein et al., 2011) lines.
To confirm that both haploid cell lines are indeed distinct given
the similarity in copy number analysis, we made use of the fact
that they were derived from oocytes of C57BL/6 3 129 inter-
crosses, in that meiotic recombination should result in distinct
haplotype structures. We compared the deep sequencing reads
to small nucleotide polymorphisms (SNPs) obtained from the
Sanger Institute release that differed between both mouse
strains. Our sequences covered 1.5 million (HMSc2) and 1.7
million (HMSc1) distinct SNPs and allowed a unique assignment
of the corresponding genomic regions to one of both parents.
Comparing the SNPs present in HMSc1 and HMSc2 cells indeed
confirmed that we had derived two independent haploid clones
(Figure S1C). In summary, the CNV analysis together with FACS
and chromosome spreads show that both cell lines are derived
independently and exclude the possiblity that HMSc1 and
HMSc2 have substantial parts of the genome or individual chro-
mosomes deleted or duplicated.
Expression of Prototypic ESC Markers
We next tested whether our haploid cell lines express prototypic
ESC markers, i.e., whether our haploid cells are indeed ESCs.
Both parthenogenetically derived haploid HMSc1 and HMSc2
lines exhibited typical morphologies of ESCs and stained posi-
tive for the ESC marker alkaline phosphatase (Figure 2A). Immu-
nolabeling to detect Oct4, Nanog, and Sox2 (Figure 2B) con-
firmed that HMSc1 and HMSc2 cells express prototypic ESC
markers. Transcriptome analysis showed that the expression
profile for both haploid cell lines closely resembled that of the
diploid ESC line IB10/C (Figure S2A). To focus on genes with
the highest discriminatory value, we analyzed a set of 100 genesCelfor maximum difference in gene expression in either direction
between mouse embryonic fibroblasts (MEFs) and diploid
ESCs, among them Nanog, Oct4, and Klf4 (Chambers et al.,
2003). Analysis of this gene set showed that both HMSc1 and
HMSc2 cell lines exhibit an expression signature that closely
resembles that of the bona fide diploid ESC line IB10/C (Fig-
ure S2B, Table S2). qPCR analyses confirmed that both
HMSc1 and HMSc2 cells express prototypic ESC markers (Fig-
ure 2C) (Elling et al., 2006; Takahashi and Yamanaka, 2006).
Taken together, global transcriptome profiling and expression
analysis of prototypic stem cell markers confirmed the ESC
nature of both haploid cell lines.
Differentiation Potential of Haploid ESCs In Vitro
To test the differentiation potential of our haploid ESCs, we first
assayed for embryoid body (EB) formation. Both haploid cell
lines readily underwent EB formation and EB cells expressed
the endodermal marker (Soudais et al., 1995) Gata4 (Figure 2D).
Differentiation was further confirmed using real time PCR. The
prototypic ESC markers Nanog, Rex1, Oct4, Sox2, Klf4, Sall4,
and Kfl2 (Chambers et al., 2003; Robertson et al., 1986; Taka-
hashi and Yamanaka, 2006) were downregulated in EBs while
mRNA expression of the lineage commitment markers (Zhang
et al., 2010) Hand1 (mesoderm and trophectoderm), Nkx2-5
and Brachyury (mesoderm), Nestin (neural), Gata4, Gata6, and
Foxa2 (all early endoderm), Sox17 (endoderm and mesoderm),
Cxcr4R (endoderm), and Keratin18 (ectoderm) was upregulated
relative to those of the parental haploid ESCs (Figure 2E, Fig-
ure S2C). These results indicate that the haploid ESCs are
capable of differentiation into several lineages of all three germ
layers.
In Vivo Differentiation Potential
To evaluate the ability of the established haploid ESC lines to
contribute to adult mice, we injected cells from the Agouti+
ESC line HMSc2 into ED 3.5 blastocysts. To assure competitive
growth and thus efficient contribution, diploid cells derived from
haploid HMSc2 were used. Coat color chimerism was observed
in 6 animals out of 25 mice born (Figure 3A). To analyze contribu-
tion of the entirely maternal- derived cells to various organs as
previously reported for parthenogenotes (Thomson and Solter,
1988), we performed a distinguishing PCR and detected
HMSc2-derived cells in multiple tissues (Figure S3A). To test
the intrinsic differentiation potential of our haploid ESCs, we per-
formed in vivo teratoma assays. Similar to diploid ESC controls,
injection of both HMSc1 and HMSc2 cells always resulted in the
formation of teratomas within 4–8 weeks.
In teratomas derived from both haploid ESC lines, we ob-
served mesoderm-derived muscle cells, endoderm-derived
Alcian-blue+ epithelial tissues that produce mucin, neuroecto-
derm-derived Tuj1+ neurons, and ectoderm-derived Cytokeratin
5+ epithelial tissues (Figure 3B). In addition, we observed bona
fide cartilage tissue, fat, keratinized multilayered epithelium,
pigmented epithelium, sebaceous sweat glands, glandular and
neuronal tubules, and ciliated respiratory epithelium (Fig-
ures S3B–S3I). These data show that haploid ESC-derived
cells have the potential to contribute to chimeric mice and
that they can differentiate in vivo into cells of all three germ
layers.l Stem Cell 9, 563–574, December 2, 2011 ª2011 Elsevier Inc. 565
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Figure 2. Marker Analysis and In Vitro Differentiation Potential of Haploid ESC Lines
(A) Both haploid HMSc1 and HMSc2 cell lines exhibit a morphology characteristic of ESC colonies (asterisk). Representative phase contrast images are shown.
Note the feeder layer of mouse embryonic fibroblasts (MEF) (arrowheads). Haploid cells stain also positive for the ESCmarker alkaline phosphatase (blue, bottom
panels).
(B) Expression of Oct4, Nanog, and Sox2, prototypical markers for murine ESCs. Phalloidin staining indicates the feeder cell layer. Haploid HMSc1 and HMSc2
cells were costained for Oct4 (FITC) and Nanog (TRITC). In both cases, stainings are shown separately in the red channel. Scale bars are 50 mm. Data are from
cells after the fourth sort.
(C) Expression of prototypic ESC marker genes in the haploid HMSc1 (blue) and HMSc2 (red) cells. mRNA expression was determined using qPCR and
normalized to diploid IB10/C ESCs (black bars). Mean and SD of three biological replicates (each done in triplicates) is shown.
(D) Gata4 protein expression in embryoid bodies (EB, day 7) as a marker for endoderm. Representative EBs are shown for both haploid HMSc1 and HMSc2 ESC
lines counterstained with phalloidin (green). Scale bars are 50 mm.
(E) qPCR revealed downregulation of the ESC markers Nanog, Rex1, Oct4, Sox2, Klf2, Klf4, and Sall4 in EBs (day 7) derived from the haploid ESC line HMSc2
accompanied by expression of the indicated lineage commitment markers (see text). mRNA expression was normalized to the parental, undifferentiated haploid
ESCs (set at 1). Mean and SD of three biological replicates (each done in triplicates) is shown.
See also Figure S2.
Cell Stem Cell
Derivation of Murine Haploid Embryonic Stem CellsThe Ability of Stable Growth and Differentiation
Is Intrinsic to Haploid ESCs
To assess whether our haploid ESCs have the intrinsic ability for
stable growth, we established several individual cell clones by
plating single haploid cells directly after FACS purification. These
subclones were established in feeder-free conditions and were
derived from both HMSc1 and HMSc2 parental lines that were
previously cultured for more than 30 passages. All derived sub-
clones expressed the stem cell markers Oct4 and Sox2 (Fig-566 Cell Stem Cell 9, 563–574, December 2, 2011 ª2011 Elsevier Incure 4A, Figure S4) and formed EBs that contained Gata4+ endo-
dermal cells and Tuj1+ neurons (Figure 4A, Figure S5). The
haploid subclone HMSc2-27 was chosen for further studies
based on its growth rates and numbers of stable haploid cells
(Figures S6A and S6B).
Typical stem cell morphologies, protein expression of Oct4,
Nanog, and Sox2, and a haploid set of chromosomes were
confirmed for the HMSc2-27 subclone (Figures S6C–S6F). The
growth rates of HMSc2-27 cells at different haploid:diploid.
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Figure 3. In Vivo Differentiation Potential of
Haploid ESC Lines
(A) Haploid ESCs can contribute to tissues in adult mice.
Diploid cells from the Agouti+ clone HMSc2 were injected
in into C57BL/6 blastocysts and coat color chimerism was
observed (brown fur patches).
(B) Histological and immunohistological analysis of tera-
tomas derived from control diploid IB10/C ESCs and the
haploid ESC lines HMSc1 and HMSc2. Haploid ESCs can
contribute to all three germ layers, namely muscle cells
(H&E), intestinal endoderm (mucin-producing goblet cells
stained by Alcian blue, counterstained with nuclear fast
red), Tuj1+ neurons, and Cytokeratin 5 (K5)-expressing
ectoderm. Tuj1+ and K5+ cells were detected by im-
munohistochemistry (DAB, brown), counterstained with
hematoxylin (blue). Scale bars: 100 mm.
See also Figure S3.
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Derivation of Murine Haploid Embryonic Stem Cellsseeding ratios were comparable to those of purely diploid
HMSc2-27 cells (Figure 4B). Of note, these growth rates are
comparable to those of previously established ESC lines. Kinetic
studies on diploid versus haploid cell ratios in cultures of
HMSc2-27 cells showed that a large fraction of these cells main-
tains haploidy for a period of seven passages (Figure 4C). Differ-
entiation of HMSc2-27 ESCs into EBs followed by lineage-
specific differentiation protocols showed that these cells have
the capability to form Gata4+ endoderm, Tuj1+ neuronal lineage
(Figure 4A), andmesodermal ‘‘beating’’ myoblasts (Figure 4D; for
synchronous contractions see Movie S1 and Movie S2). More-
over, in in vivo teratoma assays HMSc2-27 cells can differentiate
into cells of all germ layers (not shown). To confirm the subclon-
ing experiment, i.e., to make sure that cloning from a single
haploid ESC indeed works, we generated GFP+ subclones. All
cells from the established subclones expressed GFP, irrespec-
tive of whether they were at a stage of haploidy or diploidy (Fig-
ure 4E). Because diploid cells cannot become haploid, these
experiments confirm that all cells of such clones must have
been derived from a single haploid cell.
The HMSc2-27 subclone allowed us to examine the differenti-
ation potential of these cells at a haploid versus diploid state.
Haploid HMSc2-27 ESCs were indeed able to downregulate
Oct4 and form Tuj1+ neurons and Gata4+ endodermal cells in
EB cultures (Figure 4F). We next attempted to differentiate
haploid HMSc27 cells directly (without formation of EBs) into
neural and astrocyte lineages (Pollard et al., 2006). HMSc2-27
cells were able to differentiate into neural stem cells (NSCs) as
defined by Nestin expression. Moreover, upon their furtherCell Stem Cell 9, 563differentiation we observed GFAP+ astrocytes
and Tuj1+ neurons (Figure 5A and data not
shown). We next tested whether differentiation
and a state of haploidy are mutually exclusive,
i.e., whether haploid cells need to become
diploid before they differentiate. We therefore
gated for the lineage markers Oct4 and Nestin
in ESCs, NSCs, and differentiated NSC cultures
and assayed cells for DNA content. Whereas
nearly all Oct4+ cells remained haploid under
all culture conditions, we observed haploid as
well as diploid Nestin+ neural progenitor cells.However, when such neural progenitors were further differenti-
ated toward astrocytes and neurons, all Nestin+ cells became
diploid within 4 days (Figure 5B).
The differentiation capacity of haploid cells was further
assessed using high content screening analysis of Oct4 expres-
sion (Walker et al., 2007, 2010), DAPI intensity, and nuclear area,
enabling automated determination of the differentiation state of
haploid and diploid HMSc2-27 cells (Figure S7). ESCs cultured
in presence of LIF for 72 hr maintained high levels of Oct4 as de-
picted by mean Oct4 expression intensity (Figure 5C, left panel).
Distribution analysis showed that HMSc2-27 cells that became
diploid expressed a slightly higher level of Oct4 than haploid
cells, consistent with the larger nucleus. Upon LIF withdrawal,
Oct4 expression substantially decreased in haploid and diploid
HMSc2-27 cells (Figure 5C, middle panel). Moreover, differenti-
ation in response to 0.5 mM retinoic acid dramatically reduced
Oct4 expression in haploid and diploid HMSc2-27 cells to that
of background levels (Figure 5C, right panel), similar to results
obtained using 0.1 mM retinoic acid (data not shown), indicating
efficient differentiation. These data show that haploid ESCs can
differentiate at kinetics similar to those of diploid ESCs and,
importantly, that haploid stem cells can maintain haploidy even
upon initiation of differentiation.
Retroviral Mutagenesis
The idea behind establishing haploid ESCs was to create a tool
for forward and reverse genetics at the genomic scale. To dem-
onstrate the power of mutagenesis in haploid mouse ESCs, we
infected 5 3 108 cells of a freshly FACS-purified haploid culture–574, December 2, 2011 ª2011 Elsevier Inc. 567
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Figure 4. Haploid ESCs Have the Intrinsic Ability for Stable Growth and Differentiation
(A) Immunostaining for Oct4 protein expression (red) on three different subclones that were established by plating single haploid cells directly after FACS
purification (top panels). The middle and bottom panels show immunostaining for Oct4 (red) and Tuj1 (green) expression and expression of the endodermal
marker Gata4 (red, counterstained with DAPI) in attached EBs (day 10) derived from the indicated subclones. Data are from cells that were subcloned after >30
passages of the parental line. Scale bars are 50 mm.
(B and C) Proliferation rates (B) and percentages of haploid cells (C) in control cultures containing 100% diploid HMSc2-27 cells and cultures of HMSc2-27 cells
seeded at 80:20 and 50:50 ratios of haploid:diploid cells. Multiplication rates and percent haploidy were determined every 24 hr using FACS analysis of
Hoechst33342-stained cells. Note that for this experiment cells were continuously kept in culture for 7 passages (14 days). Based on this experiment, we
estimate that 2%–3% of haploid cells became diploid each day over the course of the experiment. For both (B) and (C), mean and SD of three replicates is
shown.
(D) Development of myoblasts from the haploid ESC subclone HMSc2-27. The feeder-cell-free diploid ESC line CCE was used as a control for this
experiment. Representative phase contrast images are shown (see Movie S1 and Movie S2 to watch typical ‘‘beating’’ of these myoblasts). Scale bars are
100 mm.
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Figure 5. Differentiation Potential of Haploid ESCs
(A) Analysis of the haploid ESC clone HMSc2-27 cultured
under conditions to maintain an ESC fate (ESCs), in vitro
differentiated into Nestin+ neural stem cells (NSCs), and
further differentiation into GFAP+ astrocytes by withdrawal
of EGF and FGF2 in the presence of 1% serum (differen-
tiated NSC culture conditions). Immunofluorescence
labeling of Oct4, Nestin, and GFAP are shown, counter-
stained for DAPI. Representative imagines are shown.
Scale bar is 100 mm.
(B) Flow cytometry analysis of DNA content in cells gated
for Oct4 and Nestin expression and grown under ESC
(top), NS cell (middle), and differentiated NSC (bottom
panels) conditions. The gates used and percentages of
cells are inserted in each plot. Haploid cells are prominent
in Oct4+ fractions under all conditions whereas Nestin+
cells differentiated for 4 days are devoid of haploid cells.
The red line in the top left panel shows the representative
DNA content of the diploid control IB10/C ESC line gated
for Oct4 expression.
(C) Haploid cells exit the pluripotent state following the
same dynamics as diploid cells. The left panel shows
control Oct4 levels (mean intensity depicted) in haploid
HMSc2-27, mixed (haploid and diploid) HMSc2-27, and
control diploid CCE ESCs after 72 hr under control (plus
LIF) conditions. Differentiation by LIF withdrawal leads to
diminished Oct4 expression of diploid and haploid cells
(middle panel). Differentiation induction using 0.5 mM ret-
inoic acid results in a rapid loss of Oct4 expression in both
haploid and diploid cells, indicative of differentiation (right panel). The same results were obtained whenwe used 0.1 mM retinoic acid (not shown). Data are shown
as mean Oct4 fluorescence intensity ± SEM analyzing more than 50,000 cells per condition. One-way ANOVA (p > 0.05) showed increased expression of Oct4 in
diploid cells (consistent with increased nuclear area) in all conditions except the 48 hr and 72 hr retinoic acid treatments wherein Oct4 expression was at
background levels.
See also Figure S7.
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Derivation of Murine Haploid Embryonic Stem Cellsof HMSc2-27 with a previously reported retrovirus containing
a reversible gene trap (Schnu¨tgen et al., 2008). This vector also
contains removable Oct4 binding sites (Schnu¨tgen et al., 2008),
which allow insertions into genes that showminimal or no detect-
able expression in stem cells. After infection, 7.53 106 indepen-
dent genomic insertions were generated as estimated from
colony formation assays.
ESC colonies were then pooled and 10 mg of genomic DNA
corresponding to 3 million cells was analyzed to map the viral
insertion sites by inverse PCR and deep sequencing. We could
unambiguously identify 176,178 insertions. About half of the
insertions were mapped to intergenic regions and 51% of
insertions occurred in promoter regions and intragenic regions
encompassing 8,203 different genes (50 and 30 UTR, first intronic,
other intronic, and coding regions) (Figure 6A). Among the intra-
genic insertions, approximately half (53%) were in the sense
direction, and half were in the antisense direction. Of note, we
observed frequent insertions into the first intron, which most
likely will result in complete disruption of gene expression/func-
tion. To analyze gene trap efficacy, we divided genes into 10 bins
based on their expression levels in HMSc2 cells (0%–10%
equals lowest expression, and 90%–100% equals the most(E) GFP expression (green) in a GFP-tagged haploid ESC subclone. Non-GFP labe
content (Hoechst33342) is shown for the same subclone demonstrating that bot
(F) Differentiation of haploid and diploid HMSc2-27 cells into EBs (day 13) that co
downregulation of Oct4 expression (red, upper panel) and the presence of residu
counterstained with DAPI to visualize nuclei. Scale bar is 50 mm. See also Figure
Celhighly expressed genes). As expected, more highly expressed
genes were more often hit (up to 67%). Importantly, due to the
engineered Oct4 binding sites (Schnu¨tgen et al., 2008), we
were able to obtain frequent (31%) insertions into genes that
show minimal or no detectable expression in ESCs (Figure 6B).
We next analyzed the numbers of genes that are trapped by all
176,178 insertions or fractions of the total insertions (Figure 6B;
all insertions are set to 100% at the x axis). This analysis shows
that mutagenesis has not reached saturation, indicating that
higher numbers of insertions will increase the numbers of tar-
geted genes. Considering that our library consists of 403 more
(7.5 3 106) independent integrations, our mutagenesis protocol
has, in principle, the power to disrupt most genes.
Haploid Murine ESCs as a Tool for High-Throughput
Reverse Genetics
Using our retroviral mutagenesis set-up, we next picked indi-
vidual clones, identified the insertion sites of about 1,000 cell
lines (not shown), and selected 10 cloneswith sense or antisense
insertions for further analysis. PCR analysis with site-specific
primers confirmed that our sequencing approach identified the
correct target sites in all 10 cases (Figure 6C). Most importantlyled cells are shown as control (gray shaded histogram). Flow cytometry of DNA
h haploid and diploid cells express GFP.
ntain Tuj1 neurons (green) and Gata4-expressing endodermal cells (red). Note
al clusters of Nanog+ cells (green, bottom panels). In the top panels, cells were
s S4–S6.
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A B Figure 6. Reverse Genetics in Haploid ESCs(A) Analysis of virus integration sites after neo-
mycin selection. One-hundred seventy-six thou-
sand, one-hundred seventy-eight insertions were
determined by deep sequencing. The retrovirus
landed in 49% intergenic and 51% intragenic
regions, with a high frequency of integration into
introns, especially the first intron.
(B) Graph shows percentage of genes with virus
integrations following a single round of retroviral
mutagenesis for different fractions of the total viral
integration sites (x axis). Genes with the 10%
lowest expression (0%–10%) showed the least
integration efficiency, while more highly expressed
genes (50%–100%) showed more efficient gene
trapping. For increasing fractions of the total
viral integration sites (x axis) higher saturation is
reached, up to but not exceeding a saturation of
67%, indicating that additional genes are trapped
in the total library of 7.5 million independent
insertions.
(C and D) PCR analysis using site-specific primers
for the indicated genes and a primer specific for
the LTR of the inserted retrovirus. The location of
the used PCR primers is schematically indicated
on top of each panel. Of note, all primers were
used for all 10 different genes showing (C) that the
virus has indeed integrated into the site identified
by initial sequencing and (D) that the integrations
result in homozygous mutations of the respective
loci. Lane 1 = Madcam1; lane 2 = Drosha; lane
3 = Retinoic acid receptor gamma (Rarg); lane
4 = Ap4s1; lane 5 = Arap1; lane 6 = Evx1; lane 7 =
Bcl2l1; lane 8 = 2210012G02RIK; lane 9 = Titin;
lane 10 = Chr2:50928851. Positive wild-type (WT)
and negative H2O controls are shown.
(E) qPCR analysis of RARG mRNA expression in
haploid HMSc2-27 cells that are wild-type for rarg
(WT), HMSc2-27 cells that contain the splice ac-
ceptor in antisense orientation (AS), and HMSc2-
27 cells that contain the splice acceptor in the
sense orientation (S). mRNA expression was nor-
malized to the parental HMSc2-27 cells. Mean and
SD of three replicates is shown.
(F) Representative images of cultures containing
the indicated WT, antisense, and sense RARG
HMSc2-27 cells treated with 0.1 mM retinoic acid
for 10 days. Note the near complete absence of
cells in the WT and antisense cultures. Scale bars
are 100 mm.
(G) qPCR analysis of Drosha mRNA expression in haploid HMSc2-27 cells that are wild-type for Drosha (WT), HMSc2-27 cells that contain the splice acceptor in
antisense orientation (AS), and HMSc2-27 cells that contain the splice acceptor in the sense orientation (S). mRNA expression was normalized to parental
HMSc2-27 cells. Mean and SD of three replicates is shown.
(H) Complete absence of cystic EBs in Drosha-deficient HMSc2-27 cells as compared with Drosha-expressing WT HMSc2-27 cells and cells containing the
splice acceptor in the antisense orientation. Representative images for EBs are shown on day 10 after EB induction. Of note, we did not observe a single cystic
EB in Drosha mutant cells even in prolonged culture. Scale bars are 100 mm.
(I) Histograms showing Venus reporter gene expression in wild-type HMSc2-27 cells (WT), HMSc2-27 cells that contain the splice acceptor in antisense
orientation (AS), and HMSc2-27 cells that contain the splice acceptor in the sense orientation (S) transduced with pSENSOR-based miRNA constructs harboring
a potent shRNA targeting Firefly Luciferase with (target) or without (no target) its target site in the 30 UTR of Venus. Cells were gated on shRNA-expressing
(dsRed+) cells and Venus expression levels were compared with nontransduced control cells (gray).
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Derivation of Murine Haploid Embryonic Stem Cellsthese data also show that all 10 clones carry homozygous inser-
tions (Figure 6D), indicating that mutagenesis has occurred in
haploid cells and that this approach is indeed feasible for reces-
sive genetics.
Two clones carrying insertions in the genes encoding the
retinoic acid receptor gamma (Rarg) and Drosha were function-570 Cell Stem Cell 9, 563–574, December 2, 2011 ª2011 Elsevier Incally validated using parental wild-type (WT) HMSc2-27 cells, or
ESCs clones that carry the retroviral vector in antisense orienta-
tion. By transient Cre expression we then converted the alleles
to sense integrations in which the splice acceptor disrupts
gene expression; this approach allows immediate confirmation
of the candidate gene and excludes potential background.
Cell Stem Cell
Derivation of Murine Haploid Embryonic Stem Cellsmutations. Indeed, sense, but not antisense, integrations of the
splice acceptor results in a near complete absence of Rarg
mRNA expression (Figure 6E). Functionally, whereas ESCs
carrying the WT allele or the splice acceptors in antisense orien-
tation undergo rapid differentiation and cell death upon retinoic
acid treatment, disruption of Rarg expression renders ESCs
insensitive to such retinoic acid effect (Figure 6F).
The RNase III Drosha catalyzes the conversion of pri-miRNA
transcripts into pre-miRNA stem-loop precursors in the nucleus
(Lee et al., 2003). Due to this pivotal role in the initial step of
miRNA processing, homozygous Drosha inactivation is pre-
dicted to severely impair miRNA biogenesis. While a conditional
Drosha knockout mouse has been published previously (Chong
et al., 2008), no viable Drosha knockout cell line has been re-
ported yet. We were indeed able to generate a Drosha mutant
ESC clone following Cre-mediated inversion of the splice
acceptor (Figure 6G). As reported for ESCs with mutations in
the pasha ortholog Dgcr8 (Wang et al., 2007), which together
with Drosha is part of a protein complex called the Micropro-
cessor complex (Denli et al., 2004), Droshamutant ESCs cannot
formcystic EBs (Figure 6H). To evaluate primarymiRNAprocess-
ing in ESCs harboring the disrupted Drosha allele, we monitored
the effects of a potent miR30-based shRNA (shmiR.Luc1309) on
expression of a transcript harboring a Luc1309-specific shRNA
target site (target) in the 30 UTR of a sequence encoding the
Venus reporter protein (Fellmann et al., 2011). While expression
of shmiR.Luc1309 strongly suppressed Venus expression in
normal ESCs, our Drosha-deficient ESC clone did not show
shRNA-mediated reporter suppression (Figure 6I), indicating a
dysfunctional miRNA pathway. These data show that haploid
ESCs can be indeed efficiently used for reverse genetics creating
reversible and homozygous mutations.
A Genome-Wide Screen for Genes Involved in Ricin
Toxicity
Finally, we set out to perform a recessive forward genetic screen
at the genome level using our haploid ESC system. The naturally
occurring ricin toxin from the castor oil plantRicinus communis is
highly poisonous. At the molecular level, ricin binds to N-acetyl
galactosamine or beta-1,4-linked galactose residues and man-
nose receptors on the cell surface, and ricin molecules are
thought to follow retrograde transport via the Golgi apparatus
to enter the lumen of the endoplasmic reticulum (ER), where
they escape into the cytosol to inactivate ribosomes (Spooner
and Lord, 2011). Because we found that ricin is highly toxic to
mouse ESCs, we used our mutagenized haploid HMSc2-27
cell library and challenged the cells with a lethal dose of ricin.
Whereas ricin killed all control ESCs, we observed growth of
multiple ESC colonies from the mutagenized haploid HMSc2-
27 cells (Figure 7A). These clones were then pooled and deep
sequenced so we could determine the integration sites. As ex-
pected from previous studies, we found multiple enzymes in-
volved in sugar metabolism: beta-1,4-galactosyltransferase 1
(B4galt1), N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-
transferase (Gcnt2), polypeptide N- acetylgalactosaminyltrans-
ferase2 (Galnt2), glycoprotein galactosyltransferase alpha 1,3
(Ggta1), and polypeptide N-acetylgalactosaminyltransferase3
(B4galnt3) (Figures 7B and 7C). We also obtained multiple disrup-
tive mutations in the alpha-(1,3)-fucosyltransferase Fut9, and weCelhit the GDP-fucose transporter1 Slc35c1 (Figure 7B and 7C). The
fucosylation pathway has until now never been associated with
ricin toxicity.
Intriguingly, we observed 49 different integrations in the GPCR
Gpr107 (LUSTR1) (Figure 7B), suggesting that Gpr107 is a key
molecule involved in ricin toxicity. Knockdown of Gpr107 ex-
pression in HMSc2-27 cells using shRNA technology in HMSc2
confirmed the central role of this GPCR in ricin toxicity. The
key role of Gpr107 in ricin-induced cell death was further con-
firmed in a different cell type, NIH 3T3 cells (Figures 7D and 7E).
Of note, our shRNA data are shown as ratios of viable cells
recovered from the plates with ricin treatment to those without
ricin treatment (% survival): around 1% of nontransduced or
control shRNA-transduced cells remained still viable after 48 hr
of ricin treatment, as compared with their respective nontreated
cells; shRNA-mediated knockdown of Gpr107 significantly en-
hanced survival of ricin-exposed HMSc2-27 and NIH 3T3 cells,
but did not fully protect these cells from ricin toxicity. By contrast,
genetic ablation of Gpr107 in haploid HMSc2-27 ESCs as per-
formed for the screen resulted in cells that survived ricin appli-
cation for 3 weeks and were able to expand and form colonies
starting fromsingle,mutatedcells. Thus, forwardgenetic screens
are feasible and efficient in our haploid ESCs.
DISCUSSION
Our data show that it is possible to generate mammalian haploid
ESC lines from parthenogenetic mouse blastocysts derived from
ethanol-activated oocytes. In addition, we have now also suc-
cessfully used strontium chloride to activate oocytes and derive
a third independent haploid ESC line (not shown). Detailed
molecular characterization of our haploid ESCs shows that these
cells express all classical markers of diploid ESCs, carry 20 chro-
mosomes, and largely maintain genome integrity. Functionally,
these haploid ESCs can differentiate into cells from all three
germ layers in vitro and in vivo. Although our lines and subclones
are stable and in some cases have been maintained for over 70
passages, some haploid cells become diploid. Our mutagenesis
data suggest that these cells do not become diploid via cell
fusion, but rather via failed cytokinesis and/or endoreplication
of the genome. The exact mechanism needs to be determined.
Moreover, it will be interesting to determine at what stage of
development haploid cells have to become diploid to form a
certain cell type, experiments that will be feasible using our
high-throughput imaging platform that also allows to us to track
haploidy in a single cell.
Most importantly, our haploid ESCs can be mutated and, in all
cases we have analyzed to date, these mutations are homozy-
gous, indicating that such haploid cells can be used to analyze
recessive and disease phenotypes in various cell lineages
in vitro. Although we detected contributions of our cell lines to
multiple tissues in vivo, it needs to be determined whether these
haploid cells might be able to contribute to the germline. How-
ever, germline transmission could be attempted using semi-
cloning techniques as previously reported for Medaka (Yi et al.,
2009).
Our results open the possibility of combining the power of
a haploid genome with pluripotency of ESCs. Recessive genetic
screens have elucidated a wide variety of biological processesl Stem Cell 9, 563–574, December 2, 2011 ª2011 Elsevier Inc. 571
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Figure 7. Forward Genetic Screen for Ricin
Toxicity in Haploid ESCs
(A) Haploid HMSc2-27 cells with and without gene
trap mutagenesis were exposed to ricin from
Ricinus communis for 3 weeks. Colonies only ap-
peared in the mutagenized batch and were pro-
cessed for deep sequencing.
(B) Top hits identified in the ricin toxicity screen.
Sense (green) and antisense (red) insertions in
Gpr107, Fut9, and Slc35c1 genomic loci are
shown. The vertical lines indicate the respective
exons for each gene with the first exon always
moved to the left side of each diagram. Insertions
in antisense might disrupt gene function, and
sense integrations will do so in almost all cases.
Note that nearly all insertions are in sense for the
splice acceptor and that some antisense integra-
tions map to exons, all of which should result in
disruptive mutations. Considering that 50% of
intragenic insertions are sense and 50% are
antisense, these data also show that the screen
has indeed strongly enriched for disruptive muta-
tions (p > 1.13e10 for Gpr107; p > 3.95e6 for
Fut9; p > 0.000019 for Slc35c1).
(C) Genes identified in the ricin toxicity screen. The
numbers of distinct retroviral insertions predicted
to disrupt gene expression (either because of in-
tragenic regions containing the sense orientation
of the splice acceptor, or because of sense and
antisense integrations into exons) are indicated.
Enrichment for sense mutations versus antisense
integrations was assessed using a binomial
test, and the respective p values are indicated. Of
note, antisense integrations can also lead to
gene disruption. Assigned biochemical pathways
and allocation to the Golgi apparatus are also
indicated.
(D and E) Validation of Gpr107 in ricin toxicity.
HMSc2-27 ESCs and NIH 3T3 cells were trans-
duced with LMN constructs expressing Gpr107 or
control shRNAs together with GFP, and were then
challenged with a lethal dose of ricin for 2 days.
Images show representative cultures after 48 hr of
ricin treatment (D). Scale bars are 100 mm. (E) The
ricin survival rate as a ratio between recovered
cells of ricin-treated and ricin-untreated cells is
shown in percentages (as determined by quanti-
tative FACS analysis of cells gated for viability by forward scatter, side scatter, and PI staining after 48 hr of ricin treatment). Cells were cultured in 10 cm dishes in
triplicates and average survival ± SD was determined for eGFP (not transduced) and eGFP+ haploid HMSc2-27 ESCs and NIH 3T3 cells for each plate. For (E),
Mean and SD of three replicates is shown.
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Derivation of Murine Haploid Embryonic Stem Cellsover the last century and thusmarkedly contributed to our under-
standing of normal development, basic physiology, and dis-
ease (Nu¨sslein-Volhard and Wieschaus, 1980). However, due
to the asexual proliferation cycle, saturated genetic screens in
mammals have not been possible in cell culture systems or
feasible in vivo (Carette et al., 2009). RNAi-based approaches
have therefore revolutionized functional genomics. However, in
many cases RNAi-mediated gene silencing still suffers from vari-
able knockdown, off-target effects, and transient silencing
effects (Brummelkamp et al., 2002; Carpenter and Sabatini,
2004; Fellmann et al., 2011). Recently, genome-wide saturating
genetic screens have been introduced to a human leukemia
cell line with a near haploid chromosome set (Carette et al.,
2009) and have been highly successful in, for example, eluci-572 Cell Stem Cell 9, 563–574, December 2, 2011 ª2011 Elsevier Incdating host factors of toxins or viruses (e.g., Carette et al.,
2011b).
Our experiments based on millions of different integrations
generated in a single round of retroviral infection of haploid
ESCs show that it should be possible to perform saturated
genetic recessive screens in mammalian ESCs and the many
cell types that can be derived from them. We also report that
reverse genetics is feasible using a vector system that provides
immediate confirmation of gene function in the same clones
using Cre-mediated conversion of the splice acceptor sites.
Using this system we have indeed been able to functionally vali-
date our approach using clones with conditional Rarg and
Drosha mutations. Moreover, we performed a forward genetic
screen for ricin toxicity, one of the most dangerous poisons.
Cell Stem Cell
Derivation of Murine Haploid Embryonic Stem Cellsalso being used/investigated as a biological weapon by govern-
ments. Ricin also gained notoriety for its potential use as toxin in
bioterrorism (Papaloucas et al., 2008). This screen in haploid
ESCs identified the GPCR Gpr107 as an essential molecule
required for ricin-induced killing. Since no antitoxins are avail-
able for treatment of ricin poisoning, molecular inhibition of
Gpr107 (and possibly other molecules identified by our screen)
might be useful to alleviate ricin toxicity in vivo, a hypothesis
that now needs to be tested. We anticipate that our haploid
ESCs can bridge the power of haploid organisms such as yeast
with rapid and whole-genome genetic forward screens in stem
cells or any differentiated cell type that one can derive from our
haploid mouse ESC lines.
EXPERIMENTAL PROCEDURES
Parthenogenetic Activation of Oozytes
Oocytes were collected and incubated in 5% ethanol for 5 min. Subsequently,
viable oocytes were transferred into pseudopregnant mice and blastocysts
were collected at ED 3.5.
Derivation of ESCs
Blastocysts were placed on a feeder-coated cell culture dish with ESC deriva-
tion medium as previously described (Bryja et al., 2006). Blastocyst out-
growths were trypsinized and replated on a feeder layer to allow ESC colony
outgrowth.
Genomic Sequencing
Purified DNA frommouse kidney or ESCs was sheared by sonication and sub-
jected to the Illumina adaptor ligation protocol and sequenced in Illumina
HiSeq. Reads were mapped to the genome using bowtie.
Stem Cell Characterization
Cells were analyzed for the presence of stem cell markers using qPCR
or immunofluorescent labeling and an enzymatic assay for alkaline
phosphatase.
Differentiation
Cells were differentiated by withdrawal of LIF and EB formation or by direct
neuronal differentiation (Pollard et al., 2006). For teratoma formation, cells
were injected testicularly or subcutaneously into nude mice and teratoma
growth was monitored. To generate chimeric mice, HMSc2 ESCs were in-
jected into C57BL/6 ED 3.5 blastocysts, and transferred into pseudopregnant
females. Percentage chimerism was determined by coat color.
Retroviral Infection of ESCs and Inverse PCR
Virus was packaged in Platinum E cells. Selection for gene trap insertions was
done using G418. The protocol for inverse PCRwas adapted based on Carette
et al. (2011a).
Ricin Toxicity Screen
A mutated library of cells was exposed to a lethal dose of ricin for 3 weeks.
DNA of surviving cells was purified, subjected to inverse PCR, and analyzed
by deep sequencing. For confirmation using shRNA knockdowns, cells were
exposed to ricin for 48 hr and survival was quantified using FACS.
ACCESSION NUMBERS
The microarray data have been deposited in ArrayExpress with accession
number E-MEXP-3294. All the primary sequencing data are available from
GEO with the accession number SRA047251 for CNV analysis and
GSE33184 for retroviral integration site analysis. Furthermore, primary andpro-
cessed data is accessible at http://www.starklab.org/data/elling_CSC_2011/
and formatted for uploading to the UCSC genome browser (http://genome.
ucsc.edu/).CelSUPPLEMENTAL INFORMATION
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